go back

FLT3 Duplication Amount In Leukemia

Vermont rates for HCPCS 0046U

Used in acute myeloid leukemia to assess a duplication inside the FLT3 gene, a change that affects how the disease behaves. Rather than only reporting whether the duplication is there, it measures how much duplicated sequence is present.

Rates data updated June 2026.

Facilitymedian $407 · 10th–90th $407$6760%20%40%90th$407Professionalmedian $166 · 10th–90th $115$2040%20%40%10th90th$166$100.0$200.0$500.0$1.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$114.82
Median
$114.82
Typical High
$204.17
Cigna
Setting
Facility
Modifier
Global
Typical Low
$676.08
Median
$676.08
Typical High
$676.08
Cigna
Setting
Professional
Modifier
Global
Typical Low
$407.38
Median
$407.38
Typical High
$407.38
MVP Health Care
Setting
Facility
Modifier
Global
Typical Low
$407.38
Median
$407.38
Typical High
$407.38
MVP Health Care
Setting
Professional
Modifier
Global
Typical Low
$165.96
Median
$407.38
Typical High
$407.38
United
Setting
Professional
Modifier
Global
Typical Low
$75.86
Median
$165.96
Typical High
$1,023.29